about
Acta Oncologica Lecture. Gastrointestinal consequences of cancer treatment and the wider context: a bad gut feeling.Desalted Duck Egg White Peptides Promote Calcium Uptake and Modulate Bone Formation in the Retinoic Acid-Induced Bone Loss Rat and Caco-2 Cell Model.Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.SSRIs: bad to the bone?Relationships between serum adiponectin and bone density, adiposity and calcified atherosclerotic plaque in the African American-Diabetes Heart Study.Neuroendocrine considerations in the treatment of men and women with epilepsyManagement of osteoporosis among the elderly with other chronic medical conditionsAre selective serotonin reuptake inhibitors associated with fractures?Skeletal manifestations of treatment of breast cancer.Importance of bone assessment and prevention of osteoporotic fracture in patients with prostate cancer in the gonadotropic hormone analogues use.Drug-induced osteoporosis: from Fuller Albright to aromatase inhibitors.Management of bone disease in women after breast cancer.New Target Sites for Treatment of Osteoporosis.Antiretroviral therapy and adverse skeletal effects.Premature discard of proton pump inhibitors: possible osteoporosis vs enhanced gastrointestinal bleed, adenocarcinoma efficacy.Relationship between bone cross-sectional area and indices of peripheral artery disease.Role of flavonoids on oxidative stress and mineral contents in the retinoic acid-induced bone loss model of rat.Clinical management of osteoporotic vertebral fracture treated with percutaneous vertebroplasty.Assessment and clinical management of bone disease in adults with eating disorders: a review.The Beneficial Effect of Proanthocyanidins and Icariin on Biochemical Markers of Bone Turnover in Rats
P2860
Q33460604-2559B2E8-D441-4324-82C9-F1AB47082174Q33749471-4C3A35F3-42D5-41F4-AA7D-D8E8DB7B25DDQ35754726-67567280-0B20-43B7-B81F-5D59B8663AFFQ36235126-12250366-3B7D-49B2-BD2F-EB144A1AC119Q36817256-1F5714D8-93BA-48DC-9DF4-725E045C07B2Q37055791-0FD3C24A-C6C7-44B4-B3EF-7363C0EAEC22Q37156112-59148B94-1342-4BC3-9DA6-2276F6FFB80CQ37384471-D87DF79B-7866-4007-89EA-7ADC21E6ED99Q37630298-89784643-759F-448F-AC54-66EEB6EC889FQ38493690-D5DE91D6-6A04-450B-B116-A99C3E55E1BDQ38612952-CED75298-CA40-44D7-9F84-4E24A14053B5Q38619529-2E522CD9-B10D-4B5E-A882-3EDDDE6D983FQ39151180-93417ABD-0A04-40B4-AE61-60A973896FC7Q43055326-7E600B7E-9575-4F6F-96DE-DEB610A7AACCQ43055327-48BE04A4-F447-4A7A-92C0-CA94A7F6B0A4Q43502217-3477D258-CEF2-40E2-B80F-7B9DBF57780EQ46967880-680C1007-CC9D-4897-B896-E8F576A0BEA4Q47132058-45A3FA7F-EFEA-442A-8677-932FB7B3B45AQ47163664-45E211D2-2640-4E2B-8638-4A3ECC7BDD67Q58742599-85D3EDC0-861F-4E8F-911D-6AF93D902E5F
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Update on medications with adverse skeletal effects
@ast
Update on medications with adverse skeletal effects
@en
Update on medications with adverse skeletal effects
@nl
type
label
Update on medications with adverse skeletal effects
@ast
Update on medications with adverse skeletal effects
@en
Update on medications with adverse skeletal effects
@nl
prefLabel
Update on medications with adverse skeletal effects
@ast
Update on medications with adverse skeletal effects
@en
Update on medications with adverse skeletal effects
@nl
P2860
P356
P1476
Update on medications with adverse skeletal effects
@en
P2093
Ann E Kearns
Caroline J Davidge Pitts
P2860
P304
338-43; quiz 343
P356
10.4065/MCP.2010.0636
P407
P577
2011-03-09T00:00:00Z